| Source: The Associated Press
Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
| Source: The Associated Press
Shares of some top medical devices companies are mixed at 10 a.m.:
| Source: Reuters
LONDON (Reuters) - Doctors and patients should be given clearer guidance on how to avoid bleeding risks when using Boehringer Ingelheim's new stroke prevention pill Pradaxa, European regulators said on Friday.
| Source: Reuters
WASHINGTON (Reuters) - The U.S. Senate on Thursday showed near-unanimous support for a bill that helps fund the U.S. Food and Drug Administration, a regulatory powerhouse with sweeping influence over the foods Americans eat and the medicines they take.
| Source: The Associated Press
Shares of some top pharmaceuticals companies were up at the close of trading:
| Source: The Associated Press
Shares of some top medical devices companies were up at the close of trading:
Thursday, 24 May 2012 | Source: The Associated Press
Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Thursday, 24 May 2012 | Source: The Associated Press
Shares of some top medical devices companies are mixed at 1 p.m.:
Thursday, 24 May 2012 | Source: Reuters
NEW YORK (Reuters) - Another showdown between Republicans in Congress and President Barack Obama over debt could be in the making, and some investors are already taking steps to prepare for it.
Thursday, 24 May 2012 | Source: The Associated Press
Shares of some top medical devices companies are mixed at 10 a.m.:
Thursday, 24 May 2012 | Source: The Associated Press
Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Wednesday, 23 May 2012 | Source: Reuters
SILVER SPRING, Maryland (Reuters) - U.S. advisers recommended against expanding the use of Johnson & Johnson's blood thinner Xarelto as a way to reduce the risk of new heart attacks and strokes in people with heart problems.
Wednesday, 23 May 2012 | Source: Reuters
SILVER SPRING, Maryland (Reuters) - U.S. advisers recommended against expanding the use of Johnson & Johnson's blood thinner Xarelto as a way to reduce the risk of new heart attacks and strokes in people with heart problems.
Wednesday, 23 May 2012 | Source: The Associated Press
Shares of some top pharmaceuticals companies were down at the close of trading:
Wednesday, 23 May 2012 | Source: The Associated Press
Shares of some top medical devices companies were down at the close of trading:
Posts |
COMPANY : Johnson and Johnson
23 May 2012
Check out which companies are making headlines after-the-bell Wednesday: ... Read More
22 May 2012
The SPDR Health Care Select Sector exchange-traded fund is less than a sneeze from its recent highs, and some bulls are looking for it to pop.... Read More
15 May 2012
Posted By:Antoine GaraCNBC Stock Blog
With shares tumbling after Coty, the privately held maker of Beyoncé Knowles perfume, withdrew its hotly contested $10.7 billion takeover offer, Avon Products CEO Sherilyn McCoy needs to prove to investors that a turnaround plan is possible for the beauty products giant... Read More
10 May 2012
Posted By:Richard SaintvilusCNBC Stock Blog
Few stock sectors are as reliable as drugs and health care, and astute investors know that companies such as Merck, Pfizer, and Abbott Laboratories have delivered healthy returns over the years... Read More
27 Apr 2012
There seem to be two camps: invest in bonds or stocks that yield above two percent or take the riskier route of picking stocks that can outgrow this economy... Read More
VIDEO | COMPANIES : Johnson and Johnson
Which emerging markets are most exposed to the euro zone crisis? David Riedel, Riedel Research Group, provides the best ...
Mad Money host and former hedge fund manager, Jim Cramer, provides stock traders with all manner of investing advice.
Adrian Foster, Head of Financial Markets Research, Asia Pacific, Rabobank, gives his assessment of the yen after Fitch c...
DR Horton and Mead Johnson are good stocks for those predicting a U.S. recovery, Alex Gunz, fund manager at Heptagon Cap...
CNBC's Mary Thompson reports that the Senate Banking Committee is calling JPMorgan CEO Jamie Dimon to testify.
More Videos
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
